跳至主要内容
临床试验/NCT05162989
NCT05162989已完成不适用

iCare HOME2 Clinical Trial

Icare Finland Oy2 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2021年11月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
2
主要终点
Repeatability of IOP measurements

研究概览

简要总结

The aim of this clinical study is to provide information about the variability of the intraocular pressure (IOP) self-measurements with the iCare HOME2 tonometer in comparison to the variability of the IOP measurements with the reference tonometer (iCare IC200), over a wide range of IOP values.

详细描述

The clinical study is planned to estimate the variability of the IOP measurement of iCare HOME2 and IC200. In the study, the subjects will learn to operate the iCare HOME2 tonometer independently by using the labeling materials provided to them. Once they learn to operate the tonometer, subjects will take three self-measurements on the selected eye both in sitting and supine position.

The variability of the measurement results taken with iCare HOME2 will be compared to the variability of the measurement results taken with iCare IC200 by using the recorded results from the study subjects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

Investigator cannot see both the test device and reference device measurement results.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Glaucoma patients having confirmed optic nerve damage with visual field defects consistent with the glaucomatous optic neuropathy or
  • Glaucoma-suspects being followed because of elevated IOP, and/or because of other risk factors for developing glaucoma or optic nerve damage.

排除标准

  • Active ocular infection (e.g., pink eye or infectious conjunctivitis)
  • Recent trauma to the eye including corneal laceration or corneal/scleral perforation
  • Disabling arthritis or difficulty handling the tonometer
  • Severe difficulty in opening the eyes including abnormal contractions or twitches of the eyelid (blepharospasm)
  • Involuntary, rapid, and repetitive eye movements (nystagmus)
  • Low uncorrected near visual acuity of 20/200 or below
  • Significant glaucomatous central field loss
  • Only one functional eye
  • Poor or off-center visual fixation
  • Poor hearing and/or communicates using sign language
  • Keratoconus (or other corneal disorder)
  • Congenitally small eye (microphthalmos)
  • Enlarged eyeball from the childhood glaucoma (buphthalmos)
  • Previous experience using or interacting with the HOME tonometer during usability tests or clinical trials
  • Any affiliation with Icare and its employees
  • High corneal astigmatism (>3d)
  • History of prior invasive corneal surgery including corneal laser surgery less than six months ago (e.g., LASIK, LASEK, Smile)
  • Corneal scarring
  • Very thick or very thin corneas (central corneal thickness greater than 600 μm or less than 500 μm)
  • Cataract extraction within the last 2 months
  • Wearing contact lenses during the study

结局指标

主要结局

Repeatability of IOP measurements

时间窗: Through study completion, an average of 1-2 months

Repeatability of IOP measurements comparison of iCare HOME2 vs iCare IC200

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

iCare HOME2 Clinical Trial | 临床试验